In 2012, the U.S. market for gynecological devices was valued at $1.11 billion. This report covers assisted reproduction, global endometrial ablation, uterine fibroid embolization, hysteroscopes, colposcopes, female sterilization, female urinary incontinence slings, pelvic floor electrical stimulation, endometrial resection, fluid management, pelvic organ prolapse repair and hysterosalpingography (HSG) catheters.After seeing a decline in 2011 and 2012, as a result of the global financial crisis, this market is expected to recover in 2013. The majority of the segments within this market will see steady and stable growth over the forecast period.Scope: This report pert...
No comments:
Post a Comment